Percentage of CD34+ cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count [3]

British Journal of Haematology

Volumn 130, Issue 3, 2005, Pages 460-461

  Elliot, V ^a   Marin, D ^b   Horncastle, D ^a   Elderfield, K ^a   Apperley, J F ^b   Lampert, I A ^a   Naresh, K ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bone marrow pathology; CD34; Chronic myeloid leukaemia; Chronic myeloid leukaemia stem cells; Immunocytochemistry

Indexed keywords

CD34 ANTIGEN; IMATINIB;

BLAST CELL; BONE MARROW; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CELL COUNT; CELL NUCLEUS; CHRONIC MYELOID LEUKEMIA; CORRELATION ANALYSIS; CYTOLOGY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; MORPHOMETRICS; MULTIVARIATE ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; VOLUMETRY; BLAST CELL CRISIS; BONE MARROW CELL; IMMUNOLOGY; LEUKOCYTE COUNT; PATHOLOGY; T LYMPHOCYTE;

ANTIGENS, CD34; BLAST CRISIS; BONE MARROW CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTE COUNT; T-LYMPHOCYTES;

EID: 24944509706     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05620.x     Document Type: Letter

References (6)

1. Horny H.-P. Wehrmann M. Schlicker H.U. Eichstaedt A. Clemens M.R. Kaiserling E. (1995) QBend 10 for the diagnosis of myelodysplastic syndrome in routinely processed bone marrow biopsy specimens. Journal of Clinical Pathology, 48, 291 294.
2. Orazi A. Neiman R.S. Cualing H. Heerema N.A. John K. (1994) CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukaemia. American Journal of Clinical Pathology, 101, 426 428.
3. Soligo D. Delia D. Oriani A. Cattoretti G. Orazi A. Bertolli V. Quirici N. Deliliers G.L. (1991) Identification of CD34+ cells in normal and pathologic bone marrow biopsies by QBend10 monoclonal antibody. Leukaemia, 5, 1026 1030.
4. Thiele J. Kvasnicka H.M. Fuchs N. Brunnbauer K. Volkwein N. Schmitt-Graeff A. (2003) Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. An immunohistochemical and morphometric study of sequential trephine biopsies. Haematologica, 88, 1130 1138.
5. Torlakovic G. Langholm R. Torlakovic E. (2002) CD34/QBend10 immunostaining in the bone marrow trephine biopsy. A study of CD34 positive mononuclear cells and megakaryocytes. Archives of Pathology and Laboratory Medicine, 126, 823 828.
6. Verburgh E. Achten R. Maes B. Hagemeijer A. Boogaerts M. De Wolf-Peeters C. Verhoef G. (2003) Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes. Journal of Clinical Oncology, 21, 273 282.